Noticias Nuveen Multi Asset Income Fund - NMAI | Acciones New York Stock Exchange | ADVFN

US Dollar vs MXN

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NYSE
Nuveen Multi Asset Income Fund (NMAI)
Nuveen Multi Asset Income Fund (NMAI) Noticias

Nuveen Multi Asset Income Fund (NMAI)

12.68

0.03

(0.24%)

Cerrado 26 Noviembre 3:00PM

Delayed by 15 minutes

12.68

0.00

(0.00%)

Fuera de horario: 4:59PM

Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

Form N-CSRS - Certified Shareholder Report, Semi-Annual

Form N-PX - Annual Report of proxy voting record of management investment companies

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Nuveen Closed-End Funds Announce Leading Independent Proxy Advisory Firm, Glass Lewis, Fully Supports Nuveen’s Board Nominees

The Boards of Trustees of certain Nuveen closed-end funds announced today that Glass Lewis, a leading independent proxy advisory firm...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form N-CSR - Certified Shareholder Report

Form 8-K - Current report

rrflyboy

rrflyboy 1 minuto hace

"Phunware Loss Causation Decision Dismissing The MTD With No Prejudice to Determining Still Longer Term Damage"
Thanks for the info dbing, finally a bit of sunshine may appear.
Same court, same issues, same law firm and the same plaintiff's attorney, Posner, as the NWBO case. Not sure

jondoeuk

jondoeuk 1 minuto hace

Big volume into the close, over 12 million. Someone knows something.

dinogreeves

dinogreeves 2 minutos hace

Just Wow. Some reason I knew this was coming.

Now we wait to see this strategic move

Going private? Maybe, then why file for extension or even hire an auditor, was this a last minute decision?

Buyout offer on the table? Who knows

Merger

XenaLives

XenaLives 2 minutos hace

The short whores are out in force tonight.

It seems that capitulation of short interest is imminent....

HOLD..

HOLD....

HOLD.......

https://www.youtube.com/watch?v=iDVuQi4gdtk

jimmy051357

jimmy051357 2 minutos hace

Do you think the decision to set this up to transition on Dec 30 was an accident?

DJPele

DJPele 3 minutos hace

https://x.com/hoffmann6383/status/1861618491058491410

Breaking News: Federal Court Allows Second Spoofing Case against Market Maker to Proceed

The Case: Phunware Inc. v. UBS Securities, LLC, 1:23-cv-06426 (SDNY)

Plaintiff: $PHUN
Defendant:

hardlesson

hardlesson 4 minutos hace

You might not want to lump me in to "everyone." You had shares until today, when you flip flopped again over your fears of tax loss sellers.

Your playbook is cyclical, and predictable. See you in the morning with your amusing bid whacks, because we both know you've saved some.

dinogreeves

dinogreeves 4 minutos hace

"On November 20, 2024, Super Micro Computer, Inc. (the “Company”) prepaid in full and terminated its obligations under each of (i) the Loan Agreement, by and among the Company and Cathay Bank, as amended or otherwise modified, and (ii) the Loan and Security Agreement with Bank of America N.A., by an

TrendTrade2016

TrendTrade2016 6 minutos hace

Another China monster and the clowns missed it as always

TrendTrade2016

TrendTrade2016 8 minutos hace

KDLY beautiful run

holter49

holter49 8 minutos hace

It has been a month and Patrick has been quiet. What does that say for the company performance?

muee88

muee88 8 minutos hace

Interesting. The procedural history appears to be a lot different from our case. In PHUN, the defendant’s MTD was granted but the court allowed plaintiff to file a motion to amend their complaint. It seems that in granting this motion, the Court has also allowed the case to speed past another MTD op

Kaiserwave

Kaiserwave 9 minutos hace

Shares updated on OTCM

TrendTrade2016

TrendTrade2016 10 minutos hace

MTEK next drone play… weekly breaking out.

holter49

holter49 10 minutos hace

I do not discount what you said. I knew the field of play was not level. Just like a football field bows in the middle for drainage. Most people know their are sharks in the water.

dinogreeves

dinogreeves 11 minutos hace

Yes, I don't have shares, not going to feed into paid pumpers on this board nor dirty hicks. I just like to entertain myself every now and then, IHUB is cheap entertainment, there are some good folks over on this board, Risk and OS are my favorite and a few in between, they have never disrespected

Horseb4CarT

Horseb4CarT 11 minutos hace

DALE E. HO, United States District Judge:
On April 23, 2024, this Court issued an Opinion and Order dismissing Plaintiff
Phunware, Inc.’s Complaint for failure to adequately plead loss causation. See Opinion and
Order (“Order”) at 13-16, ECF No. 30. The parties’ familiarity with

nowwhat2

nowwhat2 12 minutos hace

https://investorshub.advfn.com/uimage/uploads/2024/11/26/tj[[ebtc_111111_26_30d_833pm_CHAN_KEY_W_XRP.jpg

Begging the question : Just WHEN might the 100,000 get revisited ?.....Soon, or could it take a while ?....January 20th ?

Likewise / similarily - Th

chereb19

chereb19 13 minutos hace

He's in your head, not the other way round.

https://investorshub.advfn.com/uimage/uploads/2024/3/7/dgoetDRK.JPG

jondoeuk

jondoeuk 14 minutos hace

This will be interesting, but we know that cancer cells are able to develop multiple mechanisms that enable the evasion of NKs. These mechanisms are likely the reason why NK based therapies show only limited success in clinic trials. Here is just one mechanism (that was recently found) https://www.c

chereb19

chereb19 14 minutos hace

Dr. Mike Korenko stated “We are pleased with the FDA’s decision to grant Breakthrough Device Designation following our recent data submissions.

Viking61

Viking61 15 minutos hace

Great find Rick!!!

XenaLives

XenaLives 16 minutos hace

You implied that there was a B-12 deficiency.

My response was that given the level of supplementation in my case that is not the issue.

Note that failure to metabolize B-12 due to mitochondrial issues is not "B-12 deficiency".

It is mitochondrial failu

Nuveen Multi Asset Income

Han Alerian Midstream En...

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones